Publications by authors named "Janneke Wonders"
Article Synopsis
- Endoscopic retrograde cholangiopancreatography (ERCP) with fully covered self-expandable metal stent (FCSEMS) is the main method for biliary drainage in cases of suspected malignant biliary obstruction, but it carries a high risk of post-ERCP pancreatitis (PEP).
- A study aimed to compare the effects of performing an endoscopic sphincterotomy before FCSEMS placement versus not performing it at all on the incidence of PEP.
- The trial included 297 patients and found no significant difference in PEP rates between those who had the sphincterotomy and those who did not, leading to the conclusion that routine sphincterotomy is not necessary before FCSEMS placement
Background: Safety of thioguanine in pregnant patients with inflammatory bowel disease [IBD] is sparsely recorded. This study was aimed to document the safety of thioguanine during pregnancy and birth.
Methods: In this multicentre case series, IBD patients treated with thioguanine during pregnancy were included.
Linitis plastica is an intramural carcinoma that may occur in any hollow organ. Rectal linitis plastica (RLP) is a morphological variant cancer that may occur as a primary form of cancer or secondary as a metastasis of a primary malignancy. We report the case of a man in his 70s with RLP secondary to prostate carcinoma who was initially suspected to have an obstructing rectal adenocarcinoma.
View Article and Find Full Text PDFBackground & Aims: Ipilimumab, a monoclonal antibody against cytotoxic T-lymphocyte-associated antigen-4, is a treatment for metastatic melanoma that can induce immune-related adverse effects, such as enterocolitis. We aimed to characterize the clinical, endoscopic, and histologic features of ipilimumab-induced colitis and evaluate the efficacy of therapy for this reaction.
Methods: We performed a retrospective analysis of 27 consecutive patients who developed colitis after treatment with ipilimumab infusion therapy for castration-resistant prostate cancer or metastatic melanoma, from April 2007 through September 2012.